tiprankstipranks
Trending News
More News >
Repare Therapeutics expects cash to fund operations through 2027
PremiumThe FlyRepare Therapeutics expects cash to fund operations through 2027
2M ago
RPTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RPTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Repare Therapeutics Out-Licenses Platforms to DCx Biotherapeutics
Premium
Company Announcements
Repare Therapeutics Out-Licenses Platforms to DCx Biotherapeutics
2M ago
Repare Therapeutics: Strategic Focus and Financial Stability Underpin Buy Rating
PremiumRatingsRepare Therapeutics: Strategic Focus and Financial Stability Underpin Buy Rating
4M ago
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics
Premium
Ratings
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics
4M ago
Repare Therapeutics price target lowered to $5 from $10 at H.C. Wainwright
Premium
The Fly
Repare Therapeutics price target lowered to $5 from $10 at H.C. Wainwright
4M ago
Repare Therapeutics Announces Major Reorganization in 2025
PremiumCompany AnnouncementsRepare Therapeutics Announces Major Reorganization in 2025
4M ago
Repare Therapeutics price target lowered to $3 from $4 at Stifel
Premium
The Fly
Repare Therapeutics price target lowered to $3 from $4 at Stifel
6M ago
Repare Therapeutics Shifts Focus to Phase 1 Programs
Premium
Company Announcements
Repare Therapeutics Shifts Focus to Phase 1 Programs
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100